Cargando…
COVID-19 susceptibility and severity for dyslipidemia: A mendelian randomization investigation
BACKGROUND: The severe acute respiratory syndrome coronavirus in 2019 (COVID-19) is still spreading and causing deaths worldwide, which further increased the burden of chronic diseases. Dyslipidemia is a common metabolic syndrome, which is a major risk factor for cardiovascular disease. However, stu...
Autores principales: | Liang, Yi, Liu, Liang, Liang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560011/ https://www.ncbi.nlm.nih.gov/pubmed/37809746 http://dx.doi.org/10.1016/j.heliyon.2023.e20247 |
Ejemplares similares
-
Gout and susceptibility and severity of COVID-19: A bidirectional Mendelian randomization analysis
por: Peng, Haoxin, et al.
Publicado: (2022) -
Cancer and COVID-19 Susceptibility and Severity: A Two-Sample Mendelian Randomization and Bioinformatic Analysis
por: Zhang, Yiyin, et al.
Publicado: (2022) -
Carnitine and COVID-19 Susceptibility and Severity: A Mendelian Randomization Study
por: Li, Chunyu, et al.
Publicado: (2021) -
Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis
por: Leong, Aaron, et al.
Publicado: (2021) -
Causal relationships between rheumatism and dyslipidemia: A two-sample Mendelian randomization study
por: Zhang, Guangyang, et al.
Publicado: (2022)